Transaction DateRecipientSharesTypePriceValue
21st October 2020Kevin S. Wilson2,144Open or private sale$111.00$237,984.00
21st October 2020Kevin S. Wilson944Open or private sale$109.00$102,896.00
21st October 2020Kevin S. Wilson1,198Open or private sale$109.00$130,582.00
21st October 2020Kevin S. Wilson1,344Open or private sale$109.00$146,496.00
21st October 2020Kevin S. Wilson1,361Open or private sale$109.00$148,349.00
21st October 2020Kevin S. Wilson2,142Open or private sale$111.00$237,762.00
21st October 2020Kevin S. Wilson2,144Open or private sale$111.00$237,984.00
21st October 2020Kevin S. Wilson2,144Open or private sale$111.00$237,984.00
8th October 2020Kevin S. Wilson700Open or private sale$109.00$76,300.00
8th October 2020Kevin S. Wilson683Open or private sale$109.00$74,447.00
Heska
Heska logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.


Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. The Core Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The other segment focuses on private label vaccine and pharmaceutical production, primarily for cattle.


Ticker: HSKA
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1038133
Employees: 386
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals